Teresa von Linde

4PUBLICATIONS
51CO-AUTHORS
Molecular targetsHaematological tumoursProteomics and intermolecular interactions (excl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 03, 2026
Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.

|Jan 16, 2026
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Mar 27, 2025
Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins.

Aakriti Jain, Isaac Heremans, Gilles Rademaker

|Jul 12, 2024
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.

Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside

Pageof 1

Frequent Collaborators

3 joint publications

Charlotte J Imianowski

3 joint publications

Alberto G Conti

3 joint publications

Alexander C Evans

3 joint publications

Jie Yang